193 related articles for article (PubMed ID: 26448050)
21. Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies.
Hernández-Verdin I; Labreche K; Benazra M; Mokhtari K; Hoang-Xuan K; Alentorn A
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374413
[TBL] [Abstract][Full Text] [Related]
22. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 gene rearrangement in Jordanian follicular and diffuse large B-cell lymphomas.
Almasri NM; Al-Alami J; Faza M
Saudi Med J; 2005 Feb; 26(2):251-5. PubMed ID: 15770300
[TBL] [Abstract][Full Text] [Related]
24. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
[TBL] [Abstract][Full Text] [Related]
25. Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.
Dai ZM; He AL; Zhang WG; Liu J; Cao XM; Chen YX; Ma XR; Zhao WH; Dai ZJ
Int J Clin Exp Med; 2014; 7(12):4720-33. PubMed ID: 25663969
[TBL] [Abstract][Full Text] [Related]
26. The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma.
Kube D; Hua TD; Klöss M; Kulle B; Brockmöller J; Wojnowski L; Löffler M; Pfreundschuh M; Trümper L
Genes Immun; 2007 Mar; 8(2):164-7. PubMed ID: 17215862
[TBL] [Abstract][Full Text] [Related]
27. Recurrent aphthous stomatitis and gene variability in selected interleukins: a case-control study.
Borilova Linhartova P; Janos J; Slezakova S; Bartova J; Petanova J; Kuklinek P; Fassmann A; Dusek L; Izakovicova Holla L
Eur J Oral Sci; 2018 Dec; 126(6):485-492. PubMed ID: 30341786
[TBL] [Abstract][Full Text] [Related]
28. Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.
Jaime-Pérez JC; Gamboa-Alonso CM; Vázquez-Mellado de Larracoechea A; Rodríguez-Martínez M; Gutiérrez-Aguirre CH; Marfil-Rivera LJ; Gómez-Almaguer D
Arch Med Res; 2015 Aug; 46(6):454-61. PubMed ID: 26235285
[TBL] [Abstract][Full Text] [Related]
29. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease.
Lin Z; Wang Z; Hegarty JP; Lin TR; Wang Y; Deiling S; Wu R; Thomas NJ; Floros J
World J Gastroenterol; 2017 Jul; 23(27):4897-4909. PubMed ID: 28785144
[TBL] [Abstract][Full Text] [Related]
30. High expression of MZB1 predicts adverse prognosis in chronic lymphocytic leukemia, follicular lymphoma and diffuse large B-cell lymphoma and is associated with a unique gene expression signature.
Herold T; Mulaw MA; Jurinovic V; Seiler T; Metzeler KH; Dufour A; Schneider S; Kakadia PM; Spiekermann K; Mansmann U; Hiddemann W; Buske C; Dreyling M; Bohlander SK
Leuk Lymphoma; 2013 Aug; 54(8):1652-7. PubMed ID: 23189934
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma.
Wang SS; Maurer MJ; Morton LM; Habermann TM; Davis S; Cozen W; Lynch CF; Severson RK; Rothman N; Chanock SJ; Hartge P; Cerhan JR
Leukemia; 2009 Mar; 23(3):596-602. PubMed ID: 18830263
[No Abstract] [Full Text] [Related]
32. Polymorphisms in cytokine genes as prognostic markers in diffuse large B cell lymphoma patients treated with (R)-CHOP.
Liu D; Wang Y; Dong M; Guan S; Wang Y; Sun H; Wu N; Li S; Bai J; Chen F; Sun D; Jin Y
Ann Hematol; 2017 Feb; 96(2):227-235. PubMed ID: 27822610
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium.
Rothman N; Skibola CF; Wang SS; Morgan G; Lan Q; Smith MT; Spinelli JJ; Willett E; De Sanjose S; Cocco P; Berndt SI; Brennan P; Brooks-Wilson A; Wacholder S; Becker N; Hartge P; Zheng T; Roman E; Holly EA; Boffetta P; Armstrong B; Cozen W; Linet M; Bosch FX; Ennas MG; Holford TR; Gallagher RP; Rollinson S; Bracci PM; Cerhan JR; Whitby D; Moore PS; Leaderer B; Lai A; Spink C; Davis S; Bosch R; Scarpa A; Zhang Y; Severson RK; Yeager M; Chanock S; Nieters A
Lancet Oncol; 2006 Jan; 7(1):27-38. PubMed ID: 16389181
[TBL] [Abstract][Full Text] [Related]
34. Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk.
Nieters A; Beckmann L; Deeg E; Becker N
Genes Immun; 2006 Dec; 7(8):615-24. PubMed ID: 16971956
[TBL] [Abstract][Full Text] [Related]
35. Association of AMP-activated protein kinase with risk and progression of non-Hodgkin lymphoma.
Hoffman AE; Demanelis K; Fu A; Zheng T; Zhu Y
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):736-44. PubMed ID: 23396962
[TBL] [Abstract][Full Text] [Related]
36. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
37. Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.
Cerhan JR; Liu-Mares W; Fredericksen ZS; Novak AJ; Cunningham JM; Kay NE; Dogan A; Liebow M; Wang AH; Call TG; Habermann TM; Ansell SM; Slager SL
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3161-9. PubMed ID: 18990758
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes.
Levin LI; Ramirez CM; Liao EL; Guo H; Kim BK; Marrogi AJ; Magpantay LI; Breen EC; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):233-241. PubMed ID: 36409490
[TBL] [Abstract][Full Text] [Related]
39. Association of Q551R polymorphism in the interleukin 4 receptor gene with nonatopic asthma in Slovenian children.
Berce V; Potocnik U
Wien Klin Wochenschr; 2010 May; 122 Suppl 2():11-8. PubMed ID: 20517665
[TBL] [Abstract][Full Text] [Related]
40. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
